Full-Time
Posted on 12/6/2024
Genetic testing for rare disease diagnostics
$190k - $220kAnnually
Expert
Remote in USA
You match the following GeneDx's candidate preferences
Employers are more likely to interview you if you match these preferences:
GeneDx focuses on clinical genomics and rare disease diagnostics through genetic testing, analyzing DNA to identify mutations linked to health conditions. They have sequenced over 300,000 clinical patient exomes and provide rapid testing services, delivering results in as little as seven days. This quick turnaround is essential for timely diagnoses that can improve treatment outcomes. GeneDx aims to lead in clinical genomics by offering reliable genetic testing services that enhance patient care.
Company Size
501-1,000
Company Stage
IPO
Total Funding
$1.4B
Headquarters
Gaithersburg, Maryland
Founded
2000
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Employee Discounts
Voluntary benefits
GAITHERSBURG, Md.-(BUSINESS WIRE)- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in the 45th Annual TD Cowen Health Care Conference from March 3-5 in Boston, MA.
What You Should Know:– GeneDx, a leader in delivering improved health outcomes through genomic insights, today announced its launch on Epic Aura, a specialty diagnostics suite within Epic’s electronic health records (EHR).– The integration allows health systems to directly order GeneDx’s genetic tests, including exome sequencing (ES), whole genome sequencing (WGS), and rapid whole genome sequencing (rWGS), within their EHR systems.Enhanced Access to Genomic TestingThe integration with Epic Aura enables healthcare providers to seamlessly access GeneDx’s diagnostic services, streamlining the ordering process and accelerating the time to diagnosis for patients. By integrating with Epic Aura, health systems can now:Order GeneDx tests directly within their EHR: This eliminates the need for manual data entry and reduces the risk of errors.This eliminates the need for manual data entry and reduces the risk of errors. Receive results seamlessly: Results are automatically transmitted back to the EHR, ensuring timely access to patient information.Results are automatically transmitted back to the EHR, ensuring timely access to patient information. Improve efficiency and workflow: Streamline the diagnostic process and improve overall efficiency for clinicians.Unmatched Experience in Genomic TestingGeneDx has extensive experience in genomic testing, having sequenced over 750,000 exomes and genomes and collected millions of phenotypic data points. This vast dataset enables GeneDx to provide accurate and comprehensive diagnostic insights.Future Expansion PlansGeneDx plans to continue expanding its partnerships with health systems and integrating with other EHR platforms to further enhance access to genomic testing. The company is also committed to advancing its genomic technologies and expanding its offerings to address a wider range of genetic conditions.“GeneDx is committed to providing patient-centered solutions and our use of Aura simplifies the process for healthcare providers to ensure the first step to treatment, an accurate and fast genetic diagnosis, is easily accessible at a patient’s bedside and in the exam room,” said Katherine Stueland, President and CEO of GeneDx
In early 2024, GeneDx announced enhancements to its Whole Genome Sequencing (WGS) product, aimed at accelerating diagnoses for patients with genetic conditions.
What You Should Know:– GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.– The platform provides biopharmaceutical companies with access to de-identified and aggregated genetic data, empowering them to accelerate the development of new therapies.Addressing the Challenges of Drug DevelopmentThe traditional drug development process is lengthy, costly, and often unsuccessful. On average, it takes 12 years and $2.6 billion to bring a new drug to market, with a 90% failure rate. GeneDx Discover aims to address these challenges by leveraging the power of genetic data to improve decision-making and accelerate the development timeline.Unlocking the Potential of Genetic DataGeneDx Discover provides biopharmaceutical companies with:Access to a vast dataset: Leverages GeneDx’s industry-leading database of over 700,000 clinical exomes and genomes.Leverages GeneDx’s industry-leading database of over 700,000 clinical exomes and genomes. Self-service data exploration: Offers an easy-to-use interface for exploring and analyzing genetic data.Offers an easy-to-use interface for exploring and analyzing genetic data. Deeper understanding of patient populations: Provides insights into disease prevalence, phenotypic information, and variant-level details.Provides insights into disease prevalence, phenotypic information, and variant-level details. Enhanced decision-making: Enables data-driven decisions throughout the drug development process.Enables data-driven decisions throughout the drug development process
What You Should Know:– GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.– The platform provides biopharmaceutical companies with access to de-identified and aggregated genetic data, empowering them to accelerate the development of new therapies.Addressing the Challenges of Drug DevelopmentThe traditional drug development process is lengthy, costly, and often unsuccessful. On average, it takes 12 years and $2.6 billion to bring a new drug to market, with a 90% failure rate. GeneDx Discover aims to address these challenges by leveraging the power of genetic data to improve decision-making and accelerate the development timeline.Unlocking the Potential of Genetic DataGeneDx Discover provides biopharmaceutical companies with:Access to a vast dataset: Leverages GeneDx’s industry-leading database of over 700,000 clinical exomes and genomes.Leverages GeneDx’s industry-leading database of over 700,000 clinical exomes and genomes. Self-service data exploration: Offers an easy-to-use interface for exploring and analyzing genetic data.Offers an easy-to-use interface for exploring and analyzing genetic data. Deeper understanding of patient populations: Provides insights into disease prevalence, phenotypic information, and variant-level details.Provides insights into disease prevalence, phenotypic information, and variant-level details. Enhanced decision-making: Enables data-driven decisions throughout the drug development process.Enables data-driven decisions throughout the drug development process